Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous Serum Eye Drops in Severe Dry Eye Disease
NCT07469865Completed
- Sponsor
- Ghent University Hospital
- Start
- Nov 2021
- Primary completion
- Nov 2024
- Modality
- Biologic, NPI (Non-Pharmacological Intervention)
- Countries
- 1
01
Overview
Randomised, single-blind trial of autologous serum artificial tears in dry eye disease (DED) (6 arms), sponsored by Ghent University Hospital. Primary endpoint: Ocular Surface Disease Index at 8 weeks. Started Nov 2021; status: completed.
02
Drugs
autologous serum artificial tears
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT07469865.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07469865.